Skip to main content
. 2016 Aug 16;11:1873–1880. doi: 10.2147/COPD.S109121

Table S1.

Summary of treatment compliance in the Phase IIIb active comparator study (117115; ITT population)

Total N=905
Compliance
n 883
Compliance category, n (%)
<80 8 (<1%)
≥80 to <95 45 (5%)
≥95 to ≤105 827 (94%)
>105 to ≤120 2 (<1%)
>120 1 (<1%)

Notes: N is the number of patients in the ITT population; n is the number of patients with analyzable data.

Abbreviation: ITT, intent-to-treat.